% alzhub.org library filter % Source: https://alzhub.org/research?author=Stomrud+E&year=2021 % 12 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{pereira2021-34259835, author = {Pereira, J. B. and Janelidze, S. and Smith, R. and Mattsson-Carlgren, N. and Palmqvist, S. and Teunissen, C. E. and Zetterberg, H. and Stomrud, E. and others}, title = {{Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awab223}, pmid = {34259835}, url = {https://doi.org/10.1093/brain/awab223} } @article{janelidze2021-33165506, author = {Janelidze, S. and Berron, D. and Smith, R. and Strandberg, O. and Proctor, N. K. and Dage, J. L. and Stomrud, E. and Palmqvist, S. and others}, title = {{Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2020.4201}, pmid = {33165506}, url = {https://doi.org/10.1001/jamaneurol.2020.4201} } @article{palmqvist2021-34031605, author = {Palmqvist, S. and Tideman, P. and Cullen, N. and Zetterberg, H. and Blennow, K. and {Alzheimer’s Disease Neuroimaging Initiative} and Dage, J. L. and Stomrud, E. and others}, title = {{Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures}}, journal = {Nature medicine}, year = {2021}, doi = {10.1038/s41591-021-01348-z}, pmid = {34031605}, url = {https://doi.org/10.1038/s41591-021-01348-z} } @article{pereira2021-34077494, author = {Pereira, J. B. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and van Westen, D. and Dage, J. L. and Mattsson-Carlgren, N. and Hansson, O.}, title = {{Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awab163}, pmid = {34077494}, url = {https://doi.org/10.1093/brain/awab163} } @article{leuzy2021-34493616, author = {Leuzy, A. and Janelidze, S. and Mattsson-Carlgren, N. and Palmqvist, S. and Jacobs, D. and Cicognola, C. and Stomrud, E. and Vanmechelen, E. and others}, title = {{Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays}}, journal = {Neurology}, year = {2021}, doi = {10.1212/wnl.0000000000012727}, pmid = {34493616}, url = {https://doi.org/10.1212/wnl.0000000000012727} } @article{mattssoncarlgren2021-33949133, author = {Mattsson-Carlgren, N. and Janelidze, S. and Bateman, R. J. and Smith, R. and Stomrud, E. and Serrano, G. E. and Reiman, E. M. and Palmqvist, S. and others}, title = {{Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau}}, journal = {EMBO molecular medicine}, year = {2021}, doi = {10.15252/emmm.202114022}, pmid = {33949133}, url = {https://doi.org/10.15252/emmm.202114022} } @article{ossenkoppele2021-34254442, author = {Ossenkoppele, R. and Reimand, J. and Smith, R. and Leuzy, A. and Strandberg, O. and Palmqvist, S. and Stomrud, E. and Zetterberg, H. and others}, title = {{Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers}}, journal = {EMBO molecular medicine}, year = {2021}, doi = {10.15252/emmm.202114398}, pmid = {34254442}, url = {https://doi.org/10.15252/emmm.202114398} } @article{cullen2022-34937781, author = {Cullen, N. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Mattsson-Carlgren, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}}, title = {{Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline}}, journal = {Neurology}, year = {2022}, doi = {10.1212/wnl.0000000000013228}, pmid = {34937781}, url = {https://doi.org/10.1212/wnl.0000000000013228} } @article{cullen2021-34117234, author = {Cullen, N. C. and Leuzy, A. and Janelidze, S. and Palmqvist, S. and Svenningsson, A. L. and Stomrud, E. and Dage, J. L. and Mattsson-Carlgren, N. and others}, title = {{Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations}}, journal = {Nature communications}, year = {2021}, doi = {10.1038/s41467-021-23746-0}, pmid = {34117234}, url = {https://doi.org/10.1038/s41467-021-23746-0} } @article{janelidze2022-34151519, author = {Janelidze, S. and Palmqvist, S. and Leuzy, A. and Stomrud, E. and Verberk, I. M. W. and Zetterberg, H. and Ashton, N. J. and Pesini, P. and others}, title = {{Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2022}, doi = {10.1002/alz.12395}, pmid = {34151519}, url = {https://doi.org/10.1002/alz.12395} } @article{pereira2021-33279949, author = {Pereira, J. B. and Janelidze, S. and Ossenkoppele, R. and Kvartsberg, H. and Brinkmalm, A. and Mattsson-Carlgren, N. and Stomrud, E. and Smith, R. and others}, title = {{Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease}}, journal = {Brain : a journal of neurology}, year = {2021}, doi = {10.1093/brain/awaa395}, pmid = {33279949}, url = {https://doi.org/10.1093/brain/awaa395} } @article{johansson2021-33500386, author = {Johansson, M. and Stomrud, E. and Insel, P. S. and Leuzy, A. and Johansson, P. M. and Smith, R. and Ismail, Z. and Janelidze, S. and others}, title = {{Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease}}, journal = {Translational psychiatry}, year = {2021}, doi = {10.1038/s41398-021-01206-z}, pmid = {33500386}, url = {https://doi.org/10.1038/s41398-021-01206-z} }